Multitarget Tyrosine Kinase Inhibitors: Clinical Trials

1 recruiting. .

Follow Multitarget Tyrosine Kinase Inhibitors: new trials by email Literature Review of Multitarget Tyrosine Kinase Inhibitors trials Research Report on Multitarget Tyrosine Kinase Inhibitors

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer Multitarget Tyrosine Kinase Inhibitors, BRAF inhibitor dabrafenib and MEK inhibitor trametinib, RET Inhibitor - Thyroid Cancer, Thyroid Neoplasms		Recruiting	Fujian Medical University	120	2025-12-23	2026-02-19

Conditions studied

Thyroid Neoplasms (1)

Sponsors

Fujian Medical University (1)

Countries

China (1)